NDC 29033-020

Carbamazepine

Carbamazepine

Carbamazepine is a Oral Capsule, Extended Release in the Human Prescription Drug category. It is labeled and distributed by Nostrum Laboratories, Inc.. The primary component is Carbamazepine.

Product ID29033-020_9fcd6487-e123-44ca-a48f-3aa2e5858979
NDC29033-020
Product TypeHuman Prescription Drug
Proprietary NameCarbamazepine
Generic NameCarbamazepine
Dosage FormCapsule, Extended Release
Route of AdministrationORAL
Marketing Start Date2020-02-17
Marketing CategoryANDA / ANDA
Application NumberANDA076697
Labeler NameNostrum Laboratories, Inc.
Substance NameCARBAMAZEPINE
Active Ingredient Strength200 mg/1
Pharm ClassesDecreased Central Nervous System Disorganized Electrical Activity [PE],Mood Stabilizer [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 1A2 Inducers [MoA],Cytochrome P450 2B6 Inducers [MoA],Cytochrome P450 2C9 Inducers [MoA],Cytochrome P450 2C19 Inducers [MoA]
NDC Exclude FlagN
Listing Certified Through2021-12-31

Packaging

NDC 29033-020-12

120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (29033-020-12)
Marketing Start Date2020-02-17
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 29033-020-12 [29033002012]

Carbamazepine CAPSULE, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA076697
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitEA
Marketing Start Date2020-02-17

NDC 29033-020-30 [29033002030]

Carbamazepine CAPSULE, EXTENDED RELEASE
Marketing CategoryANDA
Application NumberANDA076697
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2020-02-17
Marketing End Date2015-03-10

Drug Details

Active Ingredients

IngredientStrength
CARBAMAZEPINE200 mg/1

Pharmacological Class

  • Decreased Central Nervous System Disorganized Electrical Activity [PE]
  • Mood Stabilizer [EPC]
  • Cytochrome P450 3A4 Inducers [MoA]
  • Cytochrome P450 1A2 Inducers [MoA]
  • Cytochrome P450 2B6 Inducers [MoA]
  • Cytochrome P450 2C9 Inducers [MoA]
  • Cytochrome P450 2C19 Inducers [MoA]

Medicade Reported Pricing

29033002012 CARBAMAZEPINE ER 200 MG CAP

Pricing Unit: EA | Drug Type:

NDC Crossover Matching brand name "Carbamazepine" or generic name "Carbamazepine"

NDCBrand NameGeneric Name
0093-0109CarbamazepineCarbamazepine
0093-0778CarbamazepineCarbamazepine
68071-3282CarbamazepineCarbamazepine
68071-4313CARBAMAZEPINECARBAMAZEPINE
68084-444CarbamazepineCarbamazepine
68094-007CarbamazepineCarbamazepine
68094-008CarbamazepineCarbamazepine
68382-555carbamazepinecarbamazepine
68382-556carbamazepinecarbamazepine
68382-557carbamazepinecarbamazepine
68788-7210CARBAMAZEPINECARBAMAZEPINE
68788-9492CARBAMAZEPINECARBAMAZEPINE
68788-9812CarbamazepineCarbamazepine
69189-0410CarbamazepineCarbamazepine
70518-0181CarbamazepineCarbamazepine
70518-0124CarbamazepineCarbamazepine
70518-0902CARBAMAZEPINECARBAMAZEPINE
70518-1769CarbamazepineCarbamazepine
70518-1436CarbamazepineCarbamazepine
70518-1545CarbamazepineCarbamazepine
70518-1433CarbamazepineCarbamazepine
70771-1470carbamazepinecarbamazepine
70771-1469carbamazepinecarbamazepine
70771-1468carbamazepinecarbamazepine
71205-025CARBAMAZEPINECARBAMAZEPINE
71335-0461CarbamazepineCarbamazepine
71335-0462CARBAMAZEPINECARBAMAZEPINE
0615-3505CarbamazepineCarbamazepine
71335-0691CARBAMAZEPINECARBAMAZEPINE
0615-4515CARBAMAZEPINECARBAMAZEPINE
0904-3854CARBAMAZEPINECARBAMAZEPINE
0904-6172CARBAMAZEPINECARBAMAZEPINE
13668-271CARBAMAZEPINECARBAMAZEPINE
13668-268CARBAMAZEPINECARBAMAZEPINE
17856-4047CarbamazepineCarbamazepine
21695-724CarbamazepineCarbamazepine
29033-004CarbamazepineCarbamazepine
33261-676CarbamazepineCarbamazepine
43063-328CarbamazepineCarbamazepine
43353-953CARBAMAZEPINECARBAMAZEPINE
49999-616CARBAMAZEPINECARBAMAZEPINE
50090-2161CARBAMAZEPINECARBAMAZEPINE
51079-385CarbamazepineCarbamazepine
51079-870CarbamazepineCarbamazepine
51655-017CARBAMAZEPINECARBAMAZEPINE
51672-4047CarbamazepineCarbamazepine
51672-4151CarbamazepineCarbamazepine
51672-4124CarbamazepineCarbamazepine
51672-4125CarbamazepineCarbamazepine
51672-4149CarbamazepineCarbamazepine
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.